The Federal Register

Agency Forms Undergoing Paperwork Reduction Act Review

Wed, Dec 18 2002 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 4981210. Send written comments to CDC, Desk Officer, Human Resources and Housing Branch, New Executive Office Building, Room 10235, Washington, DC 20503. Written comments should be received within 30 days of this notice.

Proposed Project: Requirement for a Special Permit to Import Cynomolgus, African Green, or Rhesus Monkeys into the United States (09200263)ExtensionNational Center for Infectious Diseases (NCID), Centers for Disease Control and Prevention (CDC). To receive a special permit to import cynomolgus, African green and/or rhesus monkeys, a registered importer of nonhuman primates must submit to the Director, CDC, a written plan which specifies the steps that will b

Agency Forms Undergoing Paperwork Reduction Act Review

Wed, Dec 18 2002 11:00:00 GMT

Proposed Project: PHS Supplements to the Application for Federal Assistance SF424 (09200428)ExtensionOffice of the Director (OD), Centers for Disease Control and Prevention (CDC) is requesting a three year extension for continued use of the Supplements to the Request for Federal Assistance Application, SF424. The Checklist, Program Narrative, and the Public Health System Impact Statement (PHSIS, third party notification form) are a part of the standard applic

Interagency Committee on Smoking and Health: Meeting

Wed, Dec 18 2002 11:00:00 GMT

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub L. 92463), the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) of the Centers for Disease Control and Prevention (CDC) announces the following meeting:

Name: Interagency Committee on Smoking and Health Cessation Subcommittee.

Date and Time: January 16, 2003; 8:30 a.m.2:30 p.m.

Place: Room 705A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., 7th Floor, Washington, DC 20201.

Status: Open to the public, limited only by the space available. Those who wish to attend are encouraged to register with the contact person listed below. If you will require a sign language interpreter, or have other special needs, please notify the contact person by 4:30 E.S.T. on January 14, 2003.

Purpose: The Interagency Committee on Smoking and Health advises the Secretary, Department of Health and Human Services, and the Assistant Secretary for Health in the: (a) Coordination of a

Proposed Information Collection Activity; Comment Request

Wed, Dec 18 2002 11:00:00 GMT

Title: Child Care and Development Fund Plan for States/Territories.

OMB No.: 09700114.

Description: The Child Care and Development Fund (CCDF) Plan for States and Territories is required from the Child Care Lead Agency by section 658E of the Child Care and Development Block Grant Act of 1990 (Pub. L. 101508), 42 U.S.C. 9858). The implementing regulations for the statutorily required Plan are at 45 CFR 98.10 through 98.18. The Plan, submitted on the ACF118, is required biennially and remains in effect for two years. This Plan provides ACF and the public with a description of, and assurance about, the State's child care [[Page 77498]]
program. The ACF118 is approved through February 29, 2004, making it available to States and Territories needing to submit Plan Amendments through the end of the FY 2003 Plan Period. However, in July 2003, States and Territories will be required to submit their FY 20042005 Plans. consistent with the statute and regulations, ACF requests extension of the AC

Agency Information Collection Activities; Submission for OMB Review; Comment Request; General Administrative

Wed, Dec 18 2002 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Salad Dressing Deviating From Identity Standard; Temporary Permit for Market Testing

Wed, Dec 18 2002 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing the extension of a temporary permit issued to Kraft Foods, Inc., to market test products designated as ``salad dressing'' that deviate from the U.S. standard of identity for salad dressing. The extension will allow the permit holder to continue to collect data on the consumer acceptance of products, identify mass production problems, and assess commercial feasibility, in support of a petition to amend the standard of identity for salad dressing.

Draft Guidance for Industry on Manufacture and Labeling of Raw Meat Foods for Companion and Captive Noncompanion

Wed, Dec 18 2002 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing the availability of the draft guidance for industry ([numsign]122) entitled ``Manufacture and Labeling of Raw Meat Foods for Companion and Captive Noncompanion Carnivores and Omnivores.'' This draft guidance document is intended to provide specific guidance on the manufacture and labeling of foods that contain raw meat, or other raw animal tissues, for consumption by dogs, cats, other companion or pet animals, and captive noncompanion animal carnivores and omnivores.

Request for Nominations for Members of the Chronic Fatigue Syndrome Advisory Committee

Wed, Dec 18 2002 11:00:00 GMT

The Office of Public Health and Science (OPHS), Department of Health and Human Services (DHHS), request nominations for
representatives to serve on the Chronic Fatigue Syndrome Advisory Committee (CFSAC). Nominations are solicited for biomedical research scientists with demonstrated achievements in biomedical research relating to Chronic Fatigue Syndrome (CFS); individuals with expertise in health care delivery, private health care services or insurers, or voluntary organizations concerned with the problems of individuals with CFS.

DHHS has a strong interest in ensuring that women, minority groups, and physically challenged individuals are adequately represented on the Committee and, therefore, encourages nominations of qualified candidates from these groups. DHHS also encourages geographic diversity in the composition of the Committee.

Information Required: A nominations package must include the following information for each nominee:

1. A letter of nomination stating the name,

Proposed Research Protocol: Precursors to Diabetes in Japanese American Youth

Wed, Dec 18 2002 11:00:00 GMT

On August 7, 2002, the Office of Human Research Protections (OHRP), Office of Public Health and Science, Department of Health and Human Services (HHS), gave notice (67 FR 51283) that it was proposing to recommend approval of HHS support for the research protocol entitled ``Precursors to Diabetes in Japanese American Youth,'' subject to a stipulation that certain modifications be made to the protocol and consent forms. OHRP is reopening the period for public comment and is making available additional information regarding the protocol.

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Wed, Dec 18 2002 11:00:00 GMT

Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). To request a copy of the clearance requests submitted to OMB for review, call the HRSA Reports Clearance Office on (301)4431129.

The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995:
Proposed Project: Crosssite Evaluation of the Effectiveness of the Infant Adoption Awareness Training Program (IAATP)NEW

HRSA proposes to evaluate the Infant Adoption Awareness Training Program being implemented by adoption organizations. The IAATP is authorized under the Children's Health Act of 2000 (CHA), Title XII, Subtitle A to develop, implement and evaluate curricula to achieve the goal of providing adoption information and referrals on an equal basis with othe

National Cancer Institute; Notice of Closed Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel, Spores in Pancreatic Cancer.

Date: February 2426, 2003.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: Embassy Suites, 1250 22nd Street, NW., Washington, DC 20037.

Contact Person: Brian E. Wojcik, PhD, Scientific Review Administrator, Grants Review Branch, Div

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which [[Page 77505]]
would constitute a clearly unwarranted invasion of person

National Institute of Dental & Craniofacial Research; Notice of Closed Meetings

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and
[[Page 77503]]
the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel 0329, Review of R13 Grants.

Date: December 17, 2002.

Time: 11 AM to 1 PM.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Hepatitis C Prevention Research.

Date: December 13, 2002.

Time: 3 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference

National Institute of General Medical Sciences; Notice of Closed Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, Research Centers in Trauma, Burn, and Perioperative Injury (PAR02092).

Date: January 68, 2003.

Time: 7:30 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: Marriott Boston Copley Place, 110 Huntington Avenue, Boston, MA 02116.

Contact Person: Carole

National Institute of Mental Health; Notice of Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Mental Health Council.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Advis

National Institute on Deafness and Other Communication Disorders; Notice of Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant of section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Deafness and Other Communication Disorders Advisory Council.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 542b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name

National Library of Medicine; Notice of Closed Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Library of Medicine Special Emphasis Panel, IAIMS Site VisitCincinnati, OH.

Date: January 57, 2003.

Time: January 5, 2003, 7 p.m. to 10 p.m.

Agenda: To review and evaluate grant applications.

Place: Marriott Kingsgate Conference Hotel, 151 Goodman Drive, Cincinnati, OH 45219.

Time: January 6, 2003, 8 a.m. to 5 p.m.

Agenda: To rev

Center for Scientific Review; Notice of Meeting

Wed, Dec 18 2002 11:00:00 GMT

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Center for Scientific Review Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Center for Scientific Review Advisory Committee, Workgroup.

Date: January 2728, 2003.

Time: 8:30 a.m. to 5 p.m.

Agenda: Discussion of activities to evaluate organization and function of the Center for Scientific Review Process.

Place: National Institutes of Health, Two Rockledge Center, Conference Room 6087, 6701 Rockledge Drive, Bethesda, MD 20892.

Contact Person: Brent B. Stanfield, PhD, Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockl